Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Tolosi

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Bioinformatics (Oxford, England)|May 18, 2011
Classification with correlated features: unreliability of feature ranking and solutionsLaura Tolosi, Thomas Lengauer
Plos Computational Biology|October 8, 2013
Sensitive detection of viral transcripts in human tumor transcriptomesSven-Eric Schelhorn, Matthias Fischer, Laura Tolosi, et al.
Plos One|August 23, 2007
Detection of novel amplicons in prostate cancer by comprehensive genomic profiling of prostate cancer cell lines using oligonucleotide-based arrayCGHJoern Kamradt, Volker Jung, Kerstin Wahrheit, et al.
The Journal of Clinical Investigation|May 20, 2009
Predicting drug susceptibility of non-small cell lung cancers based on genetic lesionsMartin L Sos, Kathrin Michel, Thomas Zander, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Bioinformatics (Oxford, England)|May 18, 2011
Classification with correlated features: unreliability of feature ranking and solutionsLaura Tolosi, Thomas Lengauer
Plos Computational Biology|October 8, 2013
Sensitive detection of viral transcripts in human tumor transcriptomesSven-Eric Schelhorn, Matthias Fischer, Laura Tolosi, et al.
Plos One|August 23, 2007
Detection of novel amplicons in prostate cancer by comprehensive genomic profiling of prostate cancer cell lines using oligonucleotide-based arrayCGHJoern Kamradt, Volker Jung, Kerstin Wahrheit, et al.
The Journal of Clinical Investigation|May 20, 2009
Predicting drug susceptibility of non-small cell lung cancers based on genetic lesionsMartin L Sos, Kathrin Michel, Thomas Zander, et al.
Pageof 1